Akoya Biosciences Inc reports results for the quarter ended in June - Earnings Summary

Akoya Biosciences

07/08/2023 23:06

* Akoya Biosciences Inc  AKYA.OQ  reported a quarterly
adjusted
loss of 46 cents​​ per share for the quarter ended in June. The
mean expectation of eight analysts for the quarter was for a
loss of 44 cents per share.
    * Revenue rose 31.4% to $23.52 million from a year ago;
analysts
expected $22.44 million. 
    * Akoya Biosciences Inc's reported EPS for the quarter was a
loss
of 51 cents​.
    * The mean earnings estimate of analysts had risen by
about 5.8%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates 
    * Akoya Biosciences Inc shares had fallen by 12.7% this
quarter and lost 32.6% so far this year.
    * The company reported a quarterly loss of $20.8 million.
    * Wall Street's median 12-month price target for Akoya
Biosciences
Inc is $16.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 7 at 10:06 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.44          -0.46          Missed
 Mar. 31 2023      -0.48          -0.49          Missed
 Dec. 31 2022      -0.43          -0.50          Missed
 Sep. 30 2022      -0.44          -0.47          Missed